General Biological Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares General Biological with three other
companies in this sector in Taiwan:
Holy Stone Healthcare Co Ltd
sales of 128.54 million Taiwanese Dollars [US$4.23 million]
Orient Pharma Co Ltd
(152.99 million Taiwanese Dollars [US$5.03 million]
of which 56%
was Pant Operation-Medicine Foundry and Pack), and
Taiwan Advance Bio-Pharmaceutical Inc
(151.08 million Taiwanese Dollars [US$4.97 million]
General Biological reported sales of 167.80 million Taiwanese Dollars (US$5.52 million)
December of 2015.
decrease of 15.5%
versus 2014, when the company's sales were 198.54 million Taiwanese Dollars.
The sales level in 2015 was fairly close to the level five years ago: in 2010, General Biological had sales
of 184.06 million Taiwanese Dollars.
Contributing to the drop in overall sales was the 28.2% decline
in Testing Drug-Sales, from 133.93 million Taiwanese Dollars to 96.18 million Taiwanese Dollars.
However, these declines were partially offset by the increase in sales of
Testing Drug-Testing (up 10.8% to 71.62 million Taiwanese Dollars)